Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program - Concepedia

Concepedia

Publication | Closed Access

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

80

Citations

17

References

2007

Year

Martin Filipits, Vincent Haddad, Katharina Schmid, Anh Tuan Huynh, Ariane Dunant, Fabrice André, Élisabeth Brambilla, Rolf A. Stahel, Jean‐Pierre Pignon, Jean‐Charles Soria,

Clinical Cancer Research

Abstract

MRP2 expression is an independent prognostic factor in patients with completely resected non-small cell lung cancer but neither MRP1 nor MRP2 was of predictive value in patients enrolled into the IALT.

References

	Year	Citations

Page 1